help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lui, W.-Y.
Right arrow Articles by Cheng, C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lui, W.-Y.
Right arrow Articles by Cheng, C. Y.
Endocrinology Vol. 142, No. 5 1865-1877
Copyright © 2001 by The Endocrine Society


ARTICLES

Transforming Growth Factor-ß3 Perturbs the Inter-Sertoli Tight Junction Permeability Barrier in Vitro Possibly Mediated via Its Effects on Occludin, Zonula Occludens-1, and Claudin-111

Wing-Yee Lui, Will M. Lee and C. Yan Cheng

Population Council (W.Y.L., C.Y.C.), Center for Biomedical Research, New York, New York 10021; and Department of Zoology (W.Y.L., W.M.L.), The University of Hong Kong, Hong Kong, China

Address all correspondence and requests for reprints to: C. Yan Cheng, Population Council, 1230 York Avenue, New York, New York 10021. E-mail: ycheng{at}popcbr.rockefeller.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Throughout spermatogenesis, inter-Sertoli tight junctions (TJs) that create the blood-testis barrier in the rat must be disassembled and reassembled to permit the timely passage of preleptotene spermatocytes from the basal to the adluminal compartment of the seminiferous epithelium. However, the mechanism(s) and the participating molecules that regulate this event are largely unknown. Although there is no in vitro model to study the event and regulation of inter-Sertoli TJ disassembly, primary cultures of Sertoli cells in vitro can be used to study junction assembly. In this study, we sought to investigate whether cytokines are involved in the inter-Sertoli TJ assembly in vitro. Sertoli cells isolated from 20-day-old rats were cultured at a density of 0.5–1.2 x 106 cells/cm2 on Matrigel-coated dishes or bicameral units for 8–9 days. The steady-state messenger RNA levels of basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-ß2, and TGF-ß3 at different time points were assessed by semiquantitative RT-PCR. In selected experiments, the assembly of inter-Sertoli TJs was monitored by transepithelial electrical resistance measurement. It was found that there was no change in the expression of basic fibroblast growth factor throughout the entire culture period. However, there was a 2-fold reduction in the expression of TGF-ß2 and TGF-ß3 at the time inter-Sertoli TJs were being assembled. On days 5–8, after the inter-Sertoli TJs had been assembled, the Sertoli cell steady-state messenger RNA levels of TGF-ß2 and TGF-ß3 increased by as much as 3- and 6-fold, respectively, when compared with Sertoli cells on days 1–3 when TJs were being assembled. Also, it was found that recombinant TGF-ß3 added to Sertoli cells cultured in vitro at 1.2 x 106 cells/cm2 on Matrigel-coated bicameral units perturbed the inter-Sertoli TJ permeability barrier dose-dependently. Moreover, the presence of TGF-ß3 also inhibited the transient and/or basal expression of several TJ-associated proteins, which include occludin, zonula occludens-1, and claudin-11 when inter-Sertoli TJs were being assembled in vitro. These results suggest that TGF-ß plays a crucial role in regulating the complicated biochemical events of junction assembly in the testis.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THROUGHOUT spermatogenesis, whereas one spermatogonium will differentiate into four spermatids, these developing germ cells must also transverse progressively from the basal to the adluminal compartment of the seminiferous epithelium, where fully developed spermatids (spermatozoa) are released to the tubular lumen at spermiation (for reviews, see 1, 2). Moreover, preleptotene spermatocytes must translocate across the inter-Sertoli tight junctions (TJs) that form the blood-testis barrier from the basal to the adluminal compartment of the seminiferous epithelium, on a timely basis. Without this timely movement of germ cells across the seminiferous epithelium, spermatogenesis is disrupted. However, very little attention has been given to this cellular event. Based on recent studies from this and other laboratories, we postulate that continuous, but intermittent, phases of inter-Sertoli and Sertoli-germ cell junction disassembly and reassembly must take place to facilitate the movement of developing germ cells (for review, see 3). These events apparently require the intricate participation of proteases, protease inhibitors, junctional complex components, signaling molecules, and other biomolecules (4, 5, 6, 7, 8, 9). For instance, there are transient inductions in the expression of junctional complex-associated genes, such as zonula occludens-1 (ZO-1), N-cadherin (N-Cad), and connexin 33, when inter-Sertoli cell junctions are being assembled (10). It is conceivable that these changes are part of the event involved in germ cell movement. However, the mechanism that regulates the timely expression of these genes is unknown. Therefore, it is crucial to investigate whether cytokines are involved in regulating the cascade of events leading to junction assembly, because cytokines are implicated in cell movement and cell shape changes (11, 12). More recent studies have shown that interleukin-1 and transforming growth factor (TGF)-{alpha} can induce disruption of TJ-permeability barrier, possibly by reducing or altering the distribution of ZO-1 or occludin at the sites of TJs in rat striatal endothelium and mammary epithelium (for review, see 13), illustrating the crucial role of cytokines in TJ regulation.

Several studies have shown that cytokines such as TGF-ß, basic fibroblast growth factor (bFGF), and epithelial growth factor (EGF) are synthesized and expressed by Sertoli cells; they also regulate multiple testicular functions such as somatic and germ cell division (14, 15). TGF-ß has also been implicated in initiating spermatogenesis (16). The TGF-ß superfamily is composed of many multifunctional cytokines, which include TGF-ßs, activins, inhibins, bone morphogenetic proteins, and others, which exhibit wide ranges of effects on cell growth, differentiation, adhesion, tissue morphogenesis, and matrix production (for reviews, see 17, 18, 19, 20). TGF-ß1, TGF-ß2, and TGF-ß3 are highly conserved, but distinct, isoforms. TGF-ß isoforms display similar, although not identical, biological activity and differential tissue expression (16, 21). TGF-ß3 messenger RNA (mRNA) expression is the most abundant form of TGF-ß present in the testis; its expression peaked at an early pubertal stage, at 20 days of age, coinciding with the onset of spermatogenesis (16). In view of diversified effects of TGF-ß on testicular function, we sought to investigate if this cytokine participates in regulating the events of inter-Sertoli TJ assembly. In the present study, we assessed: 1) the expression of TGF-ß isoforms at the time inter-Sertoli cell junctions were assembled; 2) whether TGF-ß3 can perturb the assembly of inter-Sertoli TJ permeability barrier; and 3) its effects on the cellular expression of TJ-associated genes at the time of inter-Sertoli TJ assembly.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Male Sprague Dawley rats at 20 days of age were obtained from Charles River Laboratories, Inc. (Kingston, MA). Rats were killed by CO2 asphyxiation, and testes were removed immediately for the isolation of testicular cells. The use of animals for this study was approved by the Rockefeller University Animal Care and Use Committee, with Protocol Numbers 00111, 97117, and 95129-R.

Preparation of Sertoli cells for culture experiments
Sertoli cell cultures. Primary Sertoli cells were isolated from 20-day-old Sprague Dawley rats as previously described (5). Freshly isolated Sertoli cells were cultured at high cell density (0.5 x 106 cells/cm2) on Matrigel (Collaborative Research, Inc., Bedford, MA)-coated 12-well dishes (effective surface area, 3.83 cm2; containing 3 ml medium, ~2 x 106 Sertoli cells in serum-free Ham’s F12 nutrition mixture and DMEM (F12/DMEM) (1:1, vol/vol) supplemented with gentamicin (20 mg/liter), 15 mM HEPES, sodium bicarbonate (1.2 g/liter), bovine insulin (10 µg/ml), human transferrin (5 µg/ml), epidermal growth factor (2.5 ng/ml), and bacitracin (5 µg/ml). Cells were then incubated at 35 C in a humidified atmosphere of 95% air-5% CO2 (vol/vol) and treated as cultures at time zero. To obtain Sertoli cell cultures with purity greater than 98%, cells were hypotonically treated with 20 mM Tris (pH 7.4), for 2.5 min, to lyse contaminating germ cells (22) 36 h after plating. The wells were washed twice with F12/DMEM. Media were replaced every 24 h, and cells were incubated for an additional 6–7 days. In those experiments where we correlate cellular gene expression and the assembly of inter-Sertoli TJs, cells were terminated at each time point within a set of experiments for RNA extraction, and all samples within an experiment were processed simultaneously for semiquantitative RT-PCR to eliminate interexperimental variations. Total RNA was extracted from Sertoli cells using RNA STAT-60 (Tel-Test "B" Inc., Friendswood, TX). To obtain Sertoli cell-enriched culture medium (SCCM), Sertoli cells were cultured at 5 x 104 cells/cm2 in 100-mm Petri dishes (~4.5 x 106 cells/9 ml F12/DMEM/100-mm dish) and incubated in a humidified atmosphere of 95% air-5% CO2 (vol/vol) at 35 C for 4 days. Spent media were collected, centrifuged at 800 x g for 30 min to remove residual Sertoli cells, followed by 3000 x g for 45 min, to remove cellular debris, concentrated by a Millipore Corp. (Bedford, MA) Minitan tangential ultrafiltration unit equipped with eight Minitan plates (Mr cut-off at 10K), and filtered through 0.2-µm filter units as described (28, 29). Protein estimation was performed by Coomassie blue-dye binding assay using BSA as a standard (23).

Sertoli cells cultured with recombinant human TGF-ß3 and bFGF protein. Sertoli cells, prepared as described above, were cultured on Matrigel-coated 12-well dishes at a density of 0.5 x 106 cells/cm2. To study the effects of cytokines on cellular gene expression at the time of inter-Sertoli TJ assembly, recombinant human TGF-ß3 protein (0.1 and 3 ng/ml; Calbiochem, La Jolla, CA) or recombinant human bFGF protein (0.01 and 3 ng/ml; PeproTech Inc., Rocky Hill, NJ) were added to Sertoli cell cultures immediately after their isolation. To prepare the stock solution, TGF-ß3 (2 µg/ml) and bFGF (100 µg/ml) were resuspended in 4 mM HCl/0.1% BSA and 5 mM Tris (pH 7.6), respectively, and they were aliquoted to F12/DMEM to desired concentrations. Cultures were hypotonically treated 36 h thereafter. Media containing TGF-ß3 or bFGF were replaced every 24 h, both in the culture dishes. Each dish had 3-ml F12/DMEM. Cultures were terminated at specific time points by RNA STAT-60. Control cultures were exposed to a similar amount of vehicle used to resuspend the recombinant protein.

Effects of human recombinant TGF-ß3 or bFGF protein on the assembly of inter-Sertoli TJs. Sertoli cells, isolated as described above, were cultured at high cell density to allow the TJ assembly. Briefly, 1.2 x 106 cells/cm2 were plated on Matrigel-coated HA filters in the apical compartment of a bicameral unit (Millipore Corp.) and treated as day zero (6, 24). To assess the assembly of inter-Sertoli TJs, transepithelial electrical resistance (TER) across the Sertoli cell epithelia was quantified using a Millicell electrical resistance system (Millipore Corp.). Briefly, a pulse of current (20 µA) was applied across the Sertoli cell epithelial between two sliver-sliver chloride electrodes, and the resistance was determined. The resistance was multiplied by the areal surface of the filter (~0.6 cm2) to yield the areal resistance (in ohm·cm2). The net value of electrical resistance was calculated by subtracting the background, which was measured by the Matrigel-coated cell-free bicameral units (6, 9). In most experiments, the first TER measurement was taken 24 h after cells were plated (i.e. day 1) so that Sertoli cells were not disturbed at the time of their attachment to the substratum (Matrigel) when forming adherens junctions. Preliminary experiments have also shown that when TER was taken from bicameral units at 3–6 h after cell plating, the subsequent TER readings to monitor the inter-Sertoli TJ-permeability barrier were at least 10 ohm·cm2 lower than cultures without having such disturbance, unless these TER readings were taken in extra bicameral units such as those shown in Fig. 1CGo. This practice, however increased the cost of each experiment. To assess the effects of TGF-ß3 on the assembly of inter-Sertoli TJ permeability barrier, Sertoli cells were exposed to TGF-ß3 at concentrations ranging between 0.005 and 3 ng/ml or bFGF (0.01–3 ng/ml) soon after their isolation. Media containing TGF-ß3 were replenished, every 24 h, in both the apical (0.5 ml) and basal (0.5 ml) compartments. Controls included Sertoli cells cultured alone in F12/DMEM without any cytokines or with vehicle (4 mM HCl/0.1% BSA). TER across the Sertoli cell epithelia was determined at specific time points. Each time point had replicate cultures, and each experiment was repeated 2–3 times using different batches of Sertoli cells. In selected experiments, the specificity of TGF-ß3 treatment was assessed. TGF-ß3 was removed by washing cells, 2.5 days after their incubation with TGF-ß3, to investigate whether its removal could restore the disrupted inter-Sertoli TJ permeability barrier.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Effects of recombinant TGF-ß3 and bFGF protein on the assembly of inter-Sertoli TJ permeability barrier in vitro. Sertoli cells (1.2 x 106 cells/cm2) were cultured on Matrigel-coated bicameral units with different concentrations of TGF-ß3 (A) and bFGF (B) throughout the culture period, followed by two washes with F12/DMEM on day 2.5 to remove the TGF-ß3 (open arrow, C). The effects of TGF-ß3 (A) and bFGF (B) on the assembly of the inter-Sertoli TJ in vitro were assessed. TER across the Sertoli cell epithelia was measured at specific time points. Each time point has duplicate cultures in each experiment, and each experiment was repeated three (A and C) or two (B) times using different batches of Sertoli cells. Results are expressed as mean ± SD (with n = 3 for A and C, and n = 4 for B). ns, Not significantly different from controls, by Student’s t test; *, significantly different from corresponding control, by Student’s t test (P < 0.05); **, significantly different from corresponding control, by Student’s t test (P < 0.01). Ctrl, Control.

 
We have chosen TER measurement to quantify the assembly and integrity of the inter-Sertoli TJ permeability barrier, over other methodologies, which include restriction of diffusion of [3H]-inulin or fluorescein isothiocyanate-labeled dextran across the Sertoli cell epithelia, maintenance of nonequilibrium of the media in the apical and basal chamber, and polarized secretion of Sertoli cell products such as transferrin, rABP, testin, clusterin, and others as described (24), for the following reasons. First, this is a technique widely adopted by cell biologists in the field (25, 26, 27). Second, it yields quantitative measurement of inter-Sertoli TJ permeability barrier rapidly, and reproducibly. Third, the technique is relatively easy to set up, and the equipment is simple to operate and maintain.

Preparation of SCCM and Sertoli cell lysates
Sertoli cells, prepared as described above, were cultured on Matrigel-coated 12-well dishes, at a density of 1 x 106 cells/cm2, for a period of up to 7 days, to allow the assembly of inter-Sertoli TJs. A set of two dishes was terminated each day to collect SCCM and to prepare cell lysate. To obtain cell lysates, cultures were briefly rinsed with 1 ml lysis buffer (17 mM MOPS, pH 6.0, containing 250 mM sucrose, 25 mM EDTA, 1.0% Triton X-100, 0.2 µg/ml pepstatin A, 1 mM phenylmethylsulfonyl fluoride, 10 mM dithiothreitol, and 5 mM MnCl2). Cells were then resuspended in 1 ml lysis buffer and incubated at 4 C for 5 min to burse cells and solubilize membrane proteins. Samples were centrifuged at 15,000 x g for 5 min at 4 C. The clear supernatant was collected and used as total cell lysates. Protein estimation was performed by Coomassie blue-dye binding (23) using BSA as a standard.

Immunoblot analysis
Protein (10–200 µg) derived from SCCM and Sertoli cell lysates was resolved onto 15% T SDS-polyacrylamide gels under reducing conditions, along with recombinant TGF-ß3, which is a known product of Sertoli cells (16). After electrophoresis, proteins were electroblotted onto nitrocellulose paper. The presence of TGF-ß3 protein was detected by immmunoblots, using a rabbit antihuman TGF-ß3 antiserum (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), essentially as previously described (28, 29).

Detection of multiple-target gene mRNAs and their changes during the assembly of inter-Sertoli TJs, with and without cytokines, by sequential use of RT-PCR
Semiquantitative RT-PCR was performed, essentially as previously described (4, 5, 6, 7, 8, 30), to detect changes in the expression of selected target genes. Briefly, approximately 2 µg total RNA was reverse-transcribed into complementary DNA (cDNA)s with 5 µg oligo(dT)15 using a Moloney murine leukemia virus RT kit (Promega Corp., Madison, WI) in a final reaction vol of 25 µl. PCR was routinely performed by combining 3 µl of the RT product with 0.4 µg each of the sense and antisense of selected target gene primer pairs coamplified with the rat ribosomal S16 primer pair (Table 1Go). Coamplification with S16 was included to ensure that equal amounts of RNA were reverse transcribed and amplified in each reaction tube. These reagents were mixed with 5 µl 10x PCR buffer, 3 µl MgCl2 (25 mM), 8 µl deoxynucleotide triphosphates (200 µM each of deoxy-ATP, deoxy-GTP, deoxycytidine triphosphate, and thymidine 5'-triphosphate), 2.5 U Taq DNA polymerase (Promega Corp.), and sterile double-distilled water, to a final vol of 50 µl. The cycling parameters for PCR reaction were as follows: denaturation at 94 C for 1 min, annealing at 56-63 C (depends on the target genes) for 2 min, and extension at 72 C for 3 min, for a total of 21–24 cycles, which were followed by an extension period at 72 C for 15 min in a Perkin-Elmer Corp. (Norwalk, CT) thermal cycler. To enhance the detection limit and to yield data for semiquantitative analysis after densitometric scanning, PCR was performed by the inclusion of trace amounts of [{gamma}-32P]-labeled primers. Briefly, the sense primer of target genes and S16, was labeled at the 5'-end with [{gamma}-32P]-deoxy-ATP (specific activity, 6000 Ci/mmol, Amersham Pharmacia Biotech, Arlington Heights, IL) using T4 polynucleotide kinase (Promega Corp.). Approximately, 1 x 106 cpm were used per PCR reaction. To ensure the linearity in the synthesis of both target genes, such as TGF-ß and S16 in the PCR, 10-µl-aliquots of PCR products at 18, 20, 22, 24, and 26 cycles were withdrawn and resolved onto 5% T polyacrylamide gels using 0.5x TBE (44.5 mM Tris-borate, 1 mM EDTA, pH 8.0) as a running buffer in preliminary experiments. Also, different concentrations of RT products and primer pairs were used in preliminary experiments to assess the appropriate conditions to be used, so that the production of both target genes and S-16 was in the linear phase. After gel electrophoresis, PCR products were visualized by ethidium bromide staining, and autoradiography was performed using X-OMAT AR x-ray film (Eastman Kodak Co., Rochester, NY). The authenticity of the PCR products, which include TGF-ß2, TGF-ß3, bFGF, ZO-1, and occludin, claudin-11, was verified by direct nucleotide sequencing after their subcloning in pGEM-T vector as previously described (8, 10). Autoradiograms from 3–4 separate experiments were densitometrically scanned at 600 nm using an Ultroscan XL Laser Densitometer (Model LKB 2222–020; Amersham Pharmacia Biotech), normalized against S-16, and used for statistical analysis.


View this table:
[in this window]
[in a new window]
 
Table 1. Primer used for RT-PCR for the analysis of mRNAs for S16, TGF-ß2, TGF-ß3, bFGF, occludin, claudin-11, and ZO-1

 
DNA assay
DNA assay was performed essentially as described (31). Sertoli cells, cultured on 12-well dishes (0.5 x 106 cells/cm2; effective surface area, 3.83 cm2; ~2 x 106 cells/3 ml F12/DMEM, prepared as described above, were harvested at specific time points by resuspending cells in 1 ml PBS (10 mM sodium phosphate, 0.15 M NaCl, pH 7.4, at 22 C). Cells were then sonicated using an ultrasonic homogenizer (Model CP50; Cole Parmer, Chicago, IL) at 40–60 amplitudes, 6 strokes, and 15 sec, on ice, in 1.5 ml Eppendorf microcentrifuge tubes (VWR, Bridgeport, NJ). A sample (~1 ml) was obtained from each culture well. To 50 µl of the sonicated sample (~0.1 x 106 cells), 50 µl of 0.05-M sulfuric acid was added, and hydrolysis was performed at 100 C for 1 h. After cooling for 5 min, 15 µl periodate reagent (0.1 M sodium metaperiodate in 9 M phosphoric acid) was added to the above sample and incubated at room temperature for 20 min. Thereafter, 100 µl arsenite solution (0.5 M sodium sulfate, containing 10% sodium arsenite and 0.05 M sulfuric acid) was added, vortexed, and incubated at room temperature for 10 min. The samples were then mixed with 300 µl thiobarbituric acid (0.6% thiobarbituric acid in 0.5 M sodium sulfate) and incubated at 100 C for 15 min. After cooling the samples to room temperature, 500 µl isoamyl alcohol was added, and they were mixed and centrifuged to facilitate separation of the immiscible solvent. The pinkish top isoamyl alcohol layer was then read at 490 nm.

Cloning and sequencing of rat claudin-11
While the mouse claudin-11 sequence is known, the rat claudin-11 nucleotide sequence was lacking, we sought to clone it by PCR. The cDNA cloning and sequencing strategy of the full-length rat claudin-11 was essentially as previously described (7, 8). A single fragment (corresponding to nucleotide 1–624) was synthesized by PCR from a rat Sertoli cell cDNA expression library. The claudin-11 specific primers: 5'-ATGGTAGCCACTTGCCTTC-3' (sense primer corresponding to nucleotides 1–19) and 5'-TTAGACATGGGCACTCTTGG-3' (antisense primer corresponding to nucleotides 605–624), were designed according to the known mouse claudin-11 full-length cDNA (32), which yielded a PCR product of 624 bp. The cDNAs with the expected size were electroeluted from the gel and subcloned into pGEM-T vector (Promega Corp.) and sequenced by the dideoxynucleotide chain termination method using Sequenase (Amersham Pharmacia Biotech) as described previously (7, 8). The entire rat claudin-11 sequence was verified by using three different cDNAs isolated in different PCR experimental sessions, and the differences between the rat and mouse cDNA sequence shown in Fig. 2Go did not seem to be the result of PCR artifacts.



View larger version (62K):
[in this window]
[in a new window]
 
Figure 2. Nucleotide sequence analysis of rat claudin-11 full-length cDNA and comparison of its deduced amino acid sequence with mouse claudin-11. The nucleotide sequence and the predicted amino acid sequence of rat claudin-11 are shown. The upper left-hand numbers designate the nucleotide positions. The right-hand numbers show the deduced amino acid positions of the protein. Rat and mouse claudin-11 display 98.6% identity at the amino acid level. Differences in the amino acid residues between rat and mouse are in a shaded box. Differences in the nucleotides between rat and mouse are underlined.

 
Statistical analysis
To assess whether there are significant changes in the steady-state mRNA levels of TGF-ß2, TGF-ß3, bFGF, occludin, and claudin-11 when inter Sertoli TJ-permeability barrier was assembled (Fig. 3Go, B, D, and F; Fig. 4BGo; Fig. 5BGo; and Fig. 6BGo) and the effects of recombinant TGF-ß3 or bFGF on the cellular expression of occludin, ZO-1, and claudin-11 at the time of inter-Sertoli TJ assembly (Fig. 4Go, D and F; Fig. 5Go, D and F; and Fig. 6DGo), statistical analyses were performed by ANOVA with Tukey’s honestly-significant-difference test using the GB-STAT statistical analysis software package (version 7.0) from Dynamic Microsystems, Inc. (Silver Spring, MD). Using Tukey’s test for ANOVA, results of individual samples were compared with the endogenous mRNA level of the corresponding target gene at time zero, when cells were plated, as well as samples within the same group with (e.g. Fig. 4Go, D and F; Fig. 5Go, D and F; Fig. 6DGo) or without (e.g. Fig. 3Go, B, D, and F; Fig. 4BGo; Fig. 5BGo; Fig. 6BGo) cytokine treatment, over the course of the experiment. Each experiment was repeated 2–3 times, and each time point had replicate cultures. Data were expressed as mean ± SD (n = 4 or 6). For results shown in Fig. 1Go and Fig. 4GGo, each data point in treatment groups (or vehicle control group) was compared with the corresponding control, by Student’s t test, using the GB-STAT software package.




View larger version (82K):
[in this window]
[in a new window]
 
Figure 3. Changes in the steady-state TGF-ß2/TGF-ß3/bFGF mRNA (A–F) and protein (G) levels when inter-Sertoli tight junctions were formed in vitro. RNA STAT-60 was added to Sertoli cells to terminate cultures at the specified time point. Semiquantitative RT-PCR was performed to assess the changes in TGF-ß2 (A), TGF-ß3 (C), and bFGF (E) steady-state mRNA level. A, C, and E are autoradiograms showing the expression of TGF-ß2, TGF-ß3, and bFGF in cultured Sertoli cells, respectively, at the time of inter-Sertoli TJ assembly. B, D, and F are the corresponding densitometrically scanned data using autoradiograms such as those shown in A, C, and E. Each bar represents mean ± SD (n = 6) of at least three separate experiments normalized against S16 in (B) and (D). Each experiment had replicate cultures. In F, only two experiments were performed. ns, Not significantly different, by ANOVA; *, significantly different, by ANOVA (P < 0.05); **, significantly different, by ANOVA (P < 0.01); H, hours; D, days. G, Increasing concentrations of recombinant human TGF-ß3 (1–100 ng) were loaded per lane onto a 15% T SDS-polyacrylamide gel under reducing (lanes 2–7) and nonreducing (lane 8) conditions along with 10–200 µg proteins from SCCM (lanes 9–11) and Sertoli cell lysates (lanes 12–14). SDS-PAGE was performed under reducing conditions except for lane 8. Proteins on the gel were then electroblotted onto nitrocellulose paper and immunostained using 1% antihuman TGF-ß3 antibody as described under Materials and Methods. It was noted that TGF-ß3 is a dimeric protein of Mr 22K (lane 8) consisting of two identical subunits of Mr 11K (lanes 6–7), as described (63 ). It took, however, at least 50 ng TGF-ß3 to be visualized by immunoblots. With this level of sensitivity, we failed to visualize TGF-ß3 in both SCCM (lanes 9–11) and SC lysates (lanes 12–14) when 10–200 µg proteins were used for immunoblot analysis. Lanes 16 and 17 illustrate the protein complexity in Sertoli cell lysate and SCCM (120 µg protein/lane), respectively, when the gel was silver stained. Lane 1, BRL prestained protein markers from Life Technologies, Inc. (Bethesda, MD); lane 15, Bio-Rad (La Jolla, CA) low molecular weight (LMW) protein standards.

 


View larger version (41K):
[in this window]
[in a new window]
 
Figure 4. Effects of recombinant TGF-ß3 on Sertoli cell occludin expression and cellular DNA content. Sertoli cells (0.5 x 106 cells/cm2 cultured on Matrigel-coated 12-well dish; each well has an effective surface area of ~3.83 cm2 containing 3 ml F12/DMEM and a total of ~2 x 106 Sertoli cells) were cultured in the presence of vehicle, 4 mM HCl in 0.1%BSA (A), 3 ng/ml TGF-ß3 (C and G), and 3 ng/ml bFGF (E). Cultures were terminated at specific time points by RNA STAT-60 for RT-PCR (A–F) or DNA assay (F). Semiquantitative RT-PCR was performed to assess the mRNA level of occludin under these culture conditions. B, D, and F are the corresponding densitometrically scanned results using autoradiograms such as those shown in A, C, and E. Results are expressed as mean ± SD (n = 6) of at least three separate experiments normalized against S16, and each experiment had replicate cultures. Statistical analysis was performed by ANOVA for B, D, and F. ns, Not significantly different, by ANOVA; *, significantly different, by ANOVA (P < 0.05); **, significantly different, by ANOVA (P < 0.01). For G, statistical analysis was performed by Student’s t test, comparing the treated group with the corresponding control.

 


View larger version (40K):
[in this window]
[in a new window]
 
Figure 5. Effects of recombinant TGF-ß3 on Sertoli cell zonula occludens-1 (ZO-1) expression. Sertoli cells (0.5 x 106 cells/cm2 cultured on Matrigel-coated 12-well dish; each well has an effective surface area of ~3.83 cm2 containing 3 ml F12/DMEM and a total of ~2 x 106 Sertoli cells) were cultured in the presence of vehicle, 4 mM HCl in 0.1%BSA (A), 3 ng/ml TGF-ß3 (C), and 3 ng/ml bFGF (E). Cultures were terminated at specific time points by RNA STAT-60. Semiquantitative RT-PCR was performed to assess the mRNA level of ZO-1 under these culture conditions. B, D, and F are the corresponding densitometrically scanned results using autoradiograms such as those shown in A, C, and E. Results are expressed as mean ± SD (n = 6) of at least three separate experiments normalized against S16, and each time point had replicate cultures. ns, Not significantly different, by ANOVA; **, significantly different, by ANOVA (P < 0.01). In D, SD bar was not shown, and ANOVA was not performed because, in two out of three separate experiments, the expression of ZO-1 was virtually undetectable, as illustrated in C. As such, it was not possible to perform densitometric scanning on two of the autoradiograms.

 


View larger version (44K):
[in this window]
[in a new window]
 
Figure 6. Effects of recombinant TGF-ß3 on Sertoli cell claudin-11 expression. Sertoli cells (0.5 x 106 cells/cm2) were cultured in the presence of vehicle, 4 mM HCl in 0.1% BSA (A), 3 ng/ml TGF-ß3 (C), and 3 ng/ml bFGF (E). Cultures were terminated at specific time points by RNA STAT-60. Semiquantitative RT-PCR was performed to assess the mRNA level of claudin-11 under these culture conditions. B and D are the corresponding densitometrically scanned results using autoradiograms such as those shown in A and C. Results are expressed as mean ± SD of at least three separate experiments normalized against S16. ns, Not significantly different, by ANOVA; **, significantly different, by ANOVA (P < 0.01).

 

    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Expression of TGF-ß2, TGF-ß3, and bFGF in cultured Sertoli cells when inter-Sertoli TJs were formed in vitro
When Sertoli cells were cultured at high cell density (0.5 x 106 cells/cm2) on Matrigel-coated dishes in serum-free F12/DMEM, to allow the assembly of inter-Sertoli TJs, it was found that there was a significant reduction in the expression of TGF-ß2 (Fig. 3Go, A and B) and TGF-ß3 (Fig. 3Go, C and D), but not bFGF (Fig. 3Go, E and F), coinciding with the assembly of inter-Sertoli TJs (Fig. 3Go vs. Fig. 1AGo). When the TER across the Sertoli cell epithelia was monitored, there was a steady rise in TER between approximately 3 h post plating and days 3–4 (Fig. 1Go A–C), illustrating the assembly of the inter-Sertoli TJ-permeability barrier. On days 5–8, after the inter-Sertoli TJs had been assembled, as manifested by a stable TER across the Sertoli cell epithelia, the expression of TGF-ß2 and TGF-ß3 were shown to be induced by as much as 2- to 3-fold (Fig. 3Go). However, there were no significant changes in the expression of bFGF throughout the entire culture period (Fig. 3Go, E and F), seemingly suggesting that TGF-ß2 and -ß3, but not bFGF, may be involved in regulation of the assembly and maintenance of inter-Sertoli TJs.

Detection of TGF-ß3 protein in Sertoli cell-conditioned media (SCCM) and Sertoli cell total cell lysates at the time of inter-Sertoli TJ assembly
Because there was a change in TGF-ß3 expression at the time of inter-Sertoli assembly, and that TGF-ß3 is a known Sertoli cell product (16), it is worthwhile to investigate the relative amounts of TGF-ß3 gene product at the time when TJs are assembled. The presence of TGF-ß3 was assessed by immunoblots using 10–200 µg protein from SCCM and Sertoli cell lysates. However, no immunoreactive TGF-ß3 could be detected by using as much as 200 µg total proteins from SCCM, because of the inherent low detection limit of immunoblots vs. RT-PCR (Fig. 3GGo vs. Fig. 3Go, A–F). As shown in Fig. 3GGo, it took as much as 50 ng recombinant TGF-ß3 to be visualized by immunoblots (Fig. 3GGo, lanes 6–8) when numerous proteins in SCCM or Sertoli lysates were detected by silver staining (Fig. 3GGo, lanes 16 and 17), whereas PCR can amplify a single copy rat sequence to as much as 0.1–1 µg DNA in 25–35 cycles (33). In the next section, it showed that as little as 3 ng recombinant TGF-ß3 could perturb the inter-Sertoli TJ permeability barrier by as much as 70%. As such, these protein data could not negate results shown in Fig. 3Go, A–F, because of the limited sensitivity of the immunoblot technique.

Effects of recombinant TGF-ß3 on the assembly of inter-Sertoli TJ permeability barrier in vitro
Because there was a significant decrease in TGF-ß2 and -ß3 expression when inter-Sertoli TJs were assembled in vitro, we sought to examine whether the presence of TGF-ß3 could perturb the inter-Sertoli TJ assembly by quantifying TER across the Sertoli cell epithelia at specified time points. It is noted that inter-Sertoli TJs began to assemble soon after cells were plated in vitro, as manifested by a rapid increase in TER across the epithelia (Fig. 1AGo). The TER reached plateau within 4 days, with a reading of 55–65 ohm/cm2, which is consistent with previously published results (6, 9). However, inclusion of TGF-ß3 perturbed the assembly of inter-Sertoli TJ permeability barrier in vitro. The presence of TGF-ß3 yielded a dose-dependent inhibitory effect on the assembly of inter-Sertoli TJs (Fig. 1AGo). The effects of TGF-ß3 on the assembly of TJ permeability barriers apparently were not the result of cell cytotoxicity, because Sertoli cells were capable of reassembling the TJ permeability barrier on removal of TGF-ß3, at day 2.5, by two successive washings (Fig. 1CGo). Also, the effects of TGF-ß3 seem to be specific, because bFGF had no effect on the assembly of inter-Sertoli TJs (Fig. 1BGo).

Effects of human recombinant TGF-ß3 on the expression of occludin in cultured Sertoli cells when inter-Sertoli TJs were assembled in vitro
We next sought to examine the mechanism by which TGF-ß3 mediates its effects on the inter-Sertoli TJ permeability barrier, as shown in Fig. 1Go. We hypothesize that TGF-ß3 may induce disruption of TJ-associated gene expression. Recent studies from this laboratory have shown that there was a significant, but transient, increase in the expression of occludin (Chung and Cheng, unpublished observations) and ZO-1 (9, 10) at the time of inter-Sertoli TJ assembly in vitro. If such timely expression can be halted by TGF-ß3, it may be the cause of TJ-disruption, because these molecules are required to maintain the dynamic nature of inter-Sertoli TJs. We thus examined the effects of TGF-ß3 on the expression of several TJ proteins, such as occludin, ZO-1, and claudin-11. As with ZO-1, there was a 2-fold increase in occludin steady-state mRNA levels in rat Sertoli cells cultured in vitro (Fig. 4Go, A and B) when inter-Sertoli TJs were assembled (Fig. 1A). However, both 0.1 (data not shown) and 3 ng/ml TGF-ß3 were capable of suppressing the transient increase in occludin expression when inter-Sertoli TJs were assembled (Fig. 4Go, C and D vs. Fig. 4Go, A and B), but the endogenous occludin steady-state mRNA level (i.e. the level of occludin expression on day zero, at the time Sertoli cells were plated) throughout the entire culture period was found not to be affected by the presence of TGF-ß3 (Fig. 4Go, C and D vs. Fig. 4Go, A and B). This TGF-ß3-induced suppression in occludin expression probably was not the result of cell death induced by TGF-ß, because the total DNA content in TGF-ß3-treated cells at all time points was not significantly different from control cultures without TGF-ß3 (Fig. 4GGo). And Sertoli cells cultured under the same conditions, with the presence of bFGF (3 ng/ml) rather than TGF-ß3, exhibited no inhibitory effect on the expression of occludin steady-state mRNA levels (Fig. 4Go, E and F).

Effects of TGF-ß3 on the expression of ZO-1 in cultured Sertoli cells when inter-Sertoli TJs were assembled in vitro
Recent occludin gene knockout studies illustrated that the occludin-deficient epithelial cells are still capable of forming a well-developed network of TJ strands (32), suggesting that other TJ-associated proteins (such as claudin-11, ZO-1, and other yet-to-be identified TJ proteins) can supersede its role in constructing and maintaining TJs. Recent studies from this laboratory have also illustrated a timely expression of ZO-1 coinciding with the assembly of inter-Sertoli TJs (10). These results thus suggest that ZO-1 also participates in TJ assembly. It is therefore worthwhile to study the effects of TGF-ß3 in regulating the expression of TJ-associated peripheral proteins such as ZO-1. The expression of ZO-1 increased by at least 5-fold on days 1–2 (Fig. 5Go, A and B) in control cultures consistent with an earlier paper (10) reporting an induction of ZO-1 at the time TJs were assembled, possibly by furnishing the building blocks needed to assemble TJs. The presence of TGF-ß3 at 3 ng/ml, however, eliminated the transient ZO-1 induction on days 1–2 (Fig. 5Go, C and D vs. Fig. 5Go, A and B). Its presence also reduced the basal ZO-1 steady-state mRNA level by as much as 5-fold (Fig. 5Go, C and D). The presence of bFGF in Sertoli cell cultures was shown to have no inhibitory effect on the expression of ZO-1 steady-state mRNA levels (Fig. 5Go, E and F vs. Fig. 5Go, A and B).

Effects of TGF-ß3 on the expression of claudin-11 in cultured Sertoli cells when inter-Sertoli TJs were assembled in vitro
Claudins (Mr, ~22K) are TJ-integral proteins, and at least 20 claudins have been identified in various TJs in different epithelia (for reviews, see 34, 35). Previous studies by Northern analyses have shown that testes express at least 7 claudins, including claudin-1, -3, -4, -5, -7, -8, and -11 (36, 37, 38, 39). Claudin-11 was selected in this study because it is found abundantly in the testis and was localized to the TJ strands of Sertoli cells when examined by immunogold electron microscopy (32). Also, claudin-11 was detected exclusively in the brain (32, 38) and the choroids plexus and the collecting ducts in the kidney (38), besides in testis. Unlike other TJ-associated proteins, such as occludin and ZO-1, the claudin-11 steady-state mRNA level remained relatively steady throughout the entire culture period, even when TJs were being assembled (Fig. 6Go, A and B). Also, there was a consistent decline in claudin-11 expression on day 7–9, when inter-Sertoli TJs were already assembled (Fig. 6Go, A and B vs. Fig. 1AGo). Addition of TGF-ß3 at 3 ng/ml, however, suppressed the expression of claudin-11 by as much as 4-fold in all time points throughout the experiment (Fig. 6Go, C and D) in a pattern similar to that of occludin and ZO-1 (Fig. 6Go vs. Figs. 4Go and 5Go), whereas TGF-ß3 (at a lower dose of 0.1 ng/ml) had no apparent effects on claudin-11 expression (data not shown). The presence of bFGF in Sertoli cell culture was shown to have no inhibitory effect on the expression of claudin-11 steady-state mRNA levels (Fig. 6EGo).

Nucleotide sequence and primary structure analysis of rat claudin-11
Because the claudin-11 sequence in the rat is not known, we have isolated the full-length rat claudin-11 cDNA by PCR. Its nucleotide sequence and the deduced amino acid sequence are shown in Fig. 2Go. This claudin-11 cDNA has an open reading frame of 621 bp coding for a 207-amino acid polypeptide. At the amino acid sequence level, rat claudin-11 displayed a 98.6% homology with the mouse homolog with differences only in 3 amino acid residues (His63, Ala78, and Gly95) in the rat vs. Tyr63, Val78, and Ala95 in the mouse; whereas, at the nucleotide level, the rat protein displayed 96.1% identity with the mouse protein (Fig. 2Go).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
It was postulated that the movement of developing germ cells from the basal to the adluminal compartment in the seminiferous epithelium, throughout spermatogenesis, likely required the participation of junction-associated proteins (such as ZO-1, occludin, and N-Cad) and nonjunctional complex proteins (such as proteases, protease inhibitors, and cytokines) via intermittent phases of inter-Sertoli and Sertoli-germ cell junction disassembly and reassembly (for reviews, see 2, 3). Previous studies from our laboratory have shown that there is a transient, but significant, increase in ZO-1 expression at the time of inter-Sertoli TJ assembly (9, 10), suggesting that the enhanced expression of ZO-1 may provide the needed building blocks to assemble TJs. In this study, the pattern of occludin expression at the time of inter-Sertoli TJ assembly was shown to be similar to that of ZO-1. Unexpectedly, we could not detect this transient induction in claudin-11. It is possible that claudin-11 is being used for other physiological roles in addition to its structural role. Previous studies have shown that claudin-11 may be involved in cell adhesion (for review, see 40). It also interacts with a member of the tetraspanin superfamily, such as OSP-interacting protein (OAP-1), and can form a complex with integrins, suggesting its possible role in cell-extracellular matrix adhesion (41). As such, its expression has to be maintained at an elevated level regardless of junction assembly.

The primary amino acid sequence of rat claudin-11 shows a high homology with the mouse homolog. Out of the 207 amino acids, rat claudin-11 differed by 3 residues, when compared with the mouse counterpart. Such striking conservation reflects the unique function of claudin-11. Previous studies revealed that claudin-11 null mice exhibited both neurological and reproductive deficits (38). Slow CNS nerve conduction and weak hind limb are found in claudin-11 null mice, and male null mice are sterile (38). Claudin-11 is the mediator of parallel-array TJ strands, which distinguishes this protein from other intrinsic TJ-membrane proteins (38). The fact that claudin-11 is required to express at a constant level vs. occludin and ZO-1 suggests its pivotal role in the junction restructuring events. These results, coupled with the effects of TGF-ß in eliminating the timely expression of occludin and ZO-1, at the time when inter-Sertoli TJs were being assembled suggest that the intricate interaction between these molecules contributes significantly to the event of TJ assembly.

Although TGF-ß3 is capable of suppressing the cellular expression of ZO-1, occludin, and claudin-11 when inter-Sertoli TJs are being assembled in vitro, its inclusion in the bicameral unit can only perturb the assembly of TJ permeability barrier but not completely abolish its formation. These observations suggest that, whereas TGF-ß3 is crucial to the assembly of inter-Sertoli TJs, it is not the only paracrine factor that participates in the regulation of TJ assembly. Also it is increasingly clear that the TJs are composed of multiple gene products, such as junction-associated molecules, occludin, and claudins (for reviews, see 34, 35, 42). As such, a TGF-ß3-induced disruption of de novo synthesis of ZO-1 and occludin cannot completely dissociate the inter-Sertoli TJs; rather, it can only perturb the TJ-barrier.

Both Sertoli and germ cells are capable of synthesizing and secreting multiple growth factors such as FGF, EGF, interferon-{alpha} and -{gamma}, and insulin-like growth factor, which all play a role in regulating testicular function (for reviews, see 15, 43, 44, 45). For instance, bFGF and EGF have been shown to affect Sertoli cell plasminogen activator inhibitor-1 expression (46). EGF can also change cell shape and reorganize the cytoskeleton, leading to cell adhesion (12). Thus, it is possible that other yet-to-be-identified cytokines, together with TGF-ß3, contribute to the assembly of inter-Sertoli TJs via different regulatory pathways.

The assembly of TJs in other epithelial cells is known to be modulated by a number of signaling molecules, which include cAMP, Ca2+, protein kinase C, G proteins, phospholipase C, and diacylglycerol (47, 48, 49, 50). In addition, the family of Ras-related small GTPase, such as RhoA and Rac1, are involved in modulating the gate and fence functions of the TJ, and they also participate in the spatial organization of TJ proteins (51). Although the signaling molecules involved in the TJ assembly have been partially identified, how these signaling molecules are being triggered, leading to TJ assembly (in particular, their role in regulating junction assembly in the testis) is entirely unknown.

Previous studies have shown that TGF-ß3 can exert its effects via the mitogen-activated protein kinase pathway. The mitogen-activated protein kinase pathway consists of the extracellular signal-regulated kinase pathway and two stress-activated pathways: those of p38 and the c-Jun N-terminal kinase (52, 53). Also, small G proteins, such as Ras and Rho-like proteins (e.g. Rac and Cdc42), provide the link between growth factor signaling and reorganization of the actin cytoskeleton (for reviews, see 54, 55), which is essential for cell adhesion and cell movement. Moreover, it has been reported that EGF and TGF-ß are possible regulators of the Rho GTPase-mediated pathway (12, 56). These small GTPases are also implicated in the signaling pathways that regulate the initiation and turnover of cell-cell adhesion, cell-substratum contact, and junction assembly via their effects on the cellular cytoskeleton network (for reviews, see 57, 58). Current investigation in our laboratory has demonstrated that both Sertoli and germ cells express RhoB, Rac2, and Cdc42 GTPases (Lui and Cheng, unpublished observations), indicating that Sertoli and germ cells are equipped with the needed machinery to link TGF-ß surface receptors to the organization of the actin cytoskeleton network, which, in turn, triggers junction assembly (56).

Apart from the MAP kinase signaling pathway, TGF-ß3 is also known to initiate its signaling process by binding to a serine/threonine kinase receptor II, a constitutively protein kinase. It then recruits, phosphorylates, and signals through type I receptor. The type I receptor kinase then activates intracellular substrates known as SMAD proteins. The receptor-regulated SMADs become phosphorylated by type I receptor. The phosphorylated receptor-regulated SMADs then form complexes with Co-SMAD, translocate into the nucleus, and induce gene transcription via specific transcription factors (18, 19, 20). Work is now in progress to use specific kinase inhibitors to identify the possible signaling pathway of TGF-ß3 in the regulation of TJ-associated protein expression during inter-Sertoli TJ assembly.

Data presented herein demonstrated that TGF-ß3 is an important cytokine in the initiation of the downstream signal transduction pathway in regulating TJ assembly. The evaluation of the function of this cytokine in the testis (in particular, its role in TJ assembly) will yield new insights into understanding testicular physiology and spermatogenesis.


    Acknowledgments
 
We thank Dr. M. Y. Mo for his excellent technical assistance in performing nucleotide sequence analysis of the rat claudin-11 cDNAs and several PCR products, which include TGF-ß2, TGF-ß3, bFGF, occludin, ZO-1, and claudin-11. We also thank Drs. Dolores Mruk and Josephine Grima for their helpful discussion and suggestions.


    Footnotes
 
1 This work was supported, in part, by grants from the Noopolis Foundation; the CONRAD program (CIG96-05-A) (to C.Y.C.) and the Hong Kong Research Grant Council (HKU 7245/00M) (to W.M.L., C.Y.C.). This work was performed as part of a dissertation submitted to the Hong Kong University Higher Degree Committee by W. Y. Lui, in the laboratory of C. Y. Cheng, in partial fulfillment of the requirements for the degree of Doctor of Philosophy. The full-length rat claudin-11 sequence has been deposited at GenBank (Accession No. AF324043). Back

Received August 22, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. de Kretser DM, Kerr JB 1988 The cytology of the testis. In: Knobil E, Neill JD, Ewing LL, Greenwald GS, Markert CL, Pfaff DW (eds) The Physiology of Reproduction. Raven Press, New York, vol 1:837–932
  2. Byers S, Pelletier RM, Suarez-Quian C 1993 Sertoli cell junctions and the seminiferous epithelium barrier. In: Russell LD, Griswold MD (eds) The Sertoli Cell. Cache River Press, Clearwater, FL, pp 431–446
  3. Mruk DD, Cheng CY 2000 Sertoli cell proteins in testicular paracriny. In: Jegou B, Pineau C, Saez J (eds) Testis, Epididymis and Technologies in the Year 2000. Springer-Verlag, Heidelberg, pp 197–228
  4. Mruk DD, Zhu LJ, Silvestrini B, Lee WM, Cheng CY 1997 Interactions of proteases and protease inhibitors in Sertoli-germ cell cocultures preceding the formation of specialized Sertoli-germ cell junction in vitro. J Androl 18:612–622[Abstract/Free Full Text]
  5. Grima J, Zhu LJ, Cheng CY 1997 Testin is tightly associated with testicular cell membrane upon its secretion by Sertoli cells whose steady-state mRNA level in the testis correlates with the turnover and integrity of inter-testicular cell junctions. J Biol Chem 272:6499–6509[Abstract/Free Full Text]
  6. Grima J, Wong CCS, Zhu LJ, Zong SD, Cheng CY 1998 Testin secreted by Sertoli cells is associated with the cell surface, and its expression correlates with the disruption of Sertoli cell junctions but not the inter-Sertoli tight junction. J Biol Chem 273:21040–21053[Abstract/Free Full Text]
  7. Chung SSW, Mo MY, Silvestrini B, Lee WM, Cheng CY 1998 Rat testicular N-cadherin: its complementary deoxyribonucleic acid cloning and regulation. Endocrinology 139:1853–1862[Abstract/Free Full Text]
  8. Mruk DD, Cheng CY 1999 Sertolin is a novel gene maker of cell-cell interactions in the rat testis. J Biol Chem 274:27056–27068[Abstract/Free Full Text]
  9. Wong CCS, Chung SSW, Grima J, Zhu LJ, Mruk D, Lee WM, Cheng CY 2000 Changes in the expression of junctional and nonjunctional complex components genes when inter-Sertoli tight junctions are formed in vitro. J Androl 21:227–237[Abstract]
  10. Chung SSW, Lee WM, Cheng CY 1999 Study on the formation of specialized inter-Sertoli cell junctions in vitro. J Cell Physiol 181:258–272[CrossRef][Medline]
  11. Gu X, Seong GJ, Lee YG, Kay EP 1996 Fibroblast growth factor 2 uses distinct signaling pathways for cell proliferation and cell shape changes in corneal endothelial cells. Invest Ophthalmol Vis Sci 37:2326–2334[Abstract/Free Full Text]
  12. Wells A, Ware MF, Allen FD, Lauffenburger DA 1999 Shaping up for shipping out: PLC{gamma} signaling of morphology changes in EGF-stimulated fibroblast migration. Cell Motil Cytoskeleton 44:227–233[CrossRef][Medline]
  13. Walsh SV, Hopkins AM, Nusrat A 2000 Modulation of tight junction structure and function by cytokines. Adv Drug Delivery Rev 41:303–313[CrossRef][Medline]
  14. Skinner MK 1991 Cell-cell interactions in the testis. Endocr Rev 12:45–77[Medline]
  15. Spiteri-Grech J, Nieschlag E 1993 Paracrine factors relevant to the regulation of spermatogenesis—a review. J Reprod Fertil 98:1–14[CrossRef][Medline]
  16. Mullaney BP, Skinner MK 1993 Transforming growth factor-ß (ß1, ß2, and ß3) gene expression and action during pubertal development of the seminiferous tubule: potential role at the onset of spermatogenesis. Mol Endocrinol 7:67–76[Abstract]
  17. Cox DA 1995 Transforming growth factor-beta 3. Cell Biol Int 19:357–371[CrossRef][Medline]
  18. Heldin CH, Miyazono K, ten Dijke P 1997 TGF-ß signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465–471[CrossRef][Medline]
  19. Piek E, Heldin CH, ten Dijke P 1999 Specificity, diversity, and regulation in TGF-ß superfamily signaling. FASEB J 13:2105–2124[Abstract/Free Full Text]
  20. Miyazono K 2000 Positive and negative regulation of TGF-ß signaling. J Cell Sci 113:1101–1109[Abstract]
  21. Graycar JL, Miller DA, Arricl BA, Lyons Rm, Moses HL, Derynck R 1989 Human transforming growth factor ß3: recombinant expression, purification, and biological activities in comparsion to transforming growth factors ß1 and ß2. Mol Endocrinol 3:1977–1986[Abstract]
  22. Galdieri M, Ziparo E, Palombi F, Russo MA, Stefanini M 1981 Pure Sertoli cell cultures: a new model for the study of somatic-germ cell interactions. J Androl 5:249–259
  23. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantites of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254[CrossRef][Medline]
  24. Grima J, Pineau C, Bardin CW, Cheng CY 1992 Rat Sertoli cell clusterin, {alpha}2-macroglobulin, and testins: biosynthesis and differential regulation by germ cells. Mol Cell Endocrinol 89:127–140[CrossRef][Medline]
  25. Janecki A, Jakubowiak A, Steinberger A 1991 Regulation of transepithelial electrical resistance in two-compartment Sertoli cell cultures: in vitro model of the blood-testis barrier. Endocrinology 129:1489–1496[Abstract]
  26. Wong V, Gumbiner BM 1997 A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136:399–409[Abstract/Free Full Text]
  27. Wong V 1997 Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol 273:C1859–C1867
  28. Cheng CY, Bardin CW 1987 Identification of two testosterone-responsive testicular proteins in Sertoli cell-enriched culture medium whose secretion is suppressed by cells of the intact seminiferous tubule. J Biol Chem 262:12768–12779[Abstract/Free Full Text]
  29. Cheng CY, Grima J, Stahler MS, Lockshin RA, Bardin CW 1989 Testin are structurally related Sertoli cell proteins whose secretion is tighly coupled to the presence of germ cells. J Biol Chem 264:21386–21393[Abstract/Free Full Text]
  30. Mruk D, Cheng CY 2000 In vitro regulation of extracellular superoxide dismutase in Sertoli cells. Life Sci 67:133–145[CrossRef][Medline]
  31. Gold DV, Shochat D 1980 A rapid colorimetric assay for the estimation of microgram quantities of DNA. Anal Biochem 105:121–125[CrossRef][Medline]
  32. Morita K, Sasaki H, Fujimoto K, Furuse M, Tsukita S 1999 Claudin-11/OSP-based tight junctions of myelin sheaths in brain and Sertoli cells in testis. J Cell Biol 145:579–588[Abstract/Free Full Text]
  33. Taylor GR 1991 Polymerase chain reaction: basic principles and automation. In: McPherson MJ, Quirke P, Taylor GR (eds) PCR. A Practical Approach. IRL Press, New York, pp 1–14
  34. Fanning AS, Mitic LL, Anderson JM 1999 Transmembrane proteins in the tight junction barrier. J Am Soc Nephrol 10:1337–1345[Abstract/Free Full Text]
  35. Tsukita S, Furuse M 2000 Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 149:13–16[Abstract/Free Full Text]
  36. Furuse M, Fujita K, Hiiragi K, Fujimoto K, Tsukita S 1998 Claudin-1 and -2: novel integral membrane proteins localizing at tight junction with no sequence similarity to occludin. J Cell Biol 141:1539–1550[Abstract/Free Full Text]
  37. Morita K, Furuse M, Fujimoto K, Tsukita S 1999 Claudin multigene family encoding four-transmembrane domains protein components of tight junction strands. Proc Natl Acad Sci USA 96:511–516[Abstract/Free Full Text]
  38. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, Danias J, Bronstein JM, Kachar B, Lazzarini RA 1999 CNS myelin and Sertoli cell tight junction strands are absent in Osp/Claudin-11 null mice. Cell 99:649–659[CrossRef][Medline]
  39. Swisshelm K, Machl A, Planitzer S, Robertson R, Kubbies M, Hosier S 1999 SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily. Gene 21:285–295
  40. Bronstein JM 2000 Function of tetraspan proteins in the myelin sheath. Curr Opin Neurobiol 10:552–557[CrossRef][Medline]
  41. Bronstein JM, Chen K, Tiwari-Woodruff S, Kornblum HI 2000 Developmental expression of OSP/claudin-11. J Neurosci Res 60:284–290[CrossRef][Medline]
  42. Mitic LL, Van Itallie CM, Anderson JM 2000 Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol 279:G250–G254
  43. Jégou B 1993 The Sertoli -germ cell communication network in mammals. Int Rev Cytol 147:25–96[Medline]
  44. Lamb DJ 1993 Growth factors and testicular development. J Urol 150:583–592[Medline]
  45. Griswold MD 1995 Interactions between germ cells and Sertoli cells in the testis. Biol Reprod 52:211–216[Abstract]
  46. Le Magueresse-Battistoni B, Pernod G, Sigillo F, Kolodie L, Benahmed M 1998 Plasminogen activator inhibitor-1 is expressed in cultured rat Sertoli cells. Biol Reprod 59:591–598[Abstract/Free Full Text]
  47. Balda MS, Gonzalez-Mariscal L, Matter K, Cereijido M, Anderson JM 1993 Assembly of the tight junction: the role of diacylglycerol. J Cell Biol 123:293–302[Abstract/Free Full Text]
  48. Anderson JM, Van Itallie CM 1995 Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 269:G467–G475
  49. Mullin JM, Kampherstein JA, Laughlin KV, Clarkin CEK, Miller RD, Szallasi Z, Kachar B, Soler AP, Rosson D 1998 Overexpression of protein kinase C-delta increases tight junction permeability in LLC-PK1 epithelia. Am J Physiol 275:C544–C554
  50. Saha C, Nigam SK, Denker BM 1998 Involvement of G{alpha}2 in the maintenance and biogenesis of epithelial cell tight junctions. J Biol Chem 273:21629–21633[Abstract/Free Full Text]
  51. Jou TS, Schneeberger EE, Nelson WJ 1998 Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases. J Cell Biol 142:101–115[Abstract/Free Full Text]
  52. Kyriakis JM, Avruch J 1996 Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 271:24313–24316[Free Full Text]
  53. Hocevar BA, Brown TL, Howe PH 1999 TGF-ß induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18:1345–1356[CrossRef][Medline]
  54. Machesky LM, Hall A 1996 Rho: a connection between membrane receptor signalling and the cyotskeleton. Trends Cell Biol 6:304–310[CrossRef][Medline]
  55. Zigmond SH 1996 Signal transduction and actin filament organization. Curr Opin Cell Biol 8:66–73[CrossRef][Medline]
  56. Engel ME, Datta PK, Moses HL 1998 Rho B is stabilized by transforming growth factor ß and antagonizes transcriptional activation. J Biol Chem 273:9921–9926[Abstract/Free Full Text]
  57. Hall A 1998 Rho GTPases and the actin cytoskeleton. Science 279:509–517[Abstract/Free Full Text]
  58. Horwitz AR, Parsons JT 1999 Cell migration—movin’ on. Science 286:1102–1103[Free Full Text]
  59. Chan YL, Paz V, Olvera J, Wool IG 1990 The primary structure of rat ribosomal protein S16. FEBS Lett 263:85–88[CrossRef][Medline]
  60. Wang J, Kuliszewski M, Yee W, Sedlackova L, Xu J, Tseu I, Post M 1995 Cloning and expression of glucocorticoid-induced genes in fetal rat lung fibroblast. Transforming growth factor-ß3. J Biol Chem 270:2722–2728[Abstract/Free Full Text]
  61. Shimasaki S, Emoto N, Koba A, Mercado M, Shibata F, Cooksey K, Baird A, Ling N 1988 Complementary DNA cloning and sequencing of rat ovarian basic fibroblast gorwth factor and tissue distribution study of its mRNA. Biochem Biophys Res Commun 157:256–263[CrossRef][Medline]
  62. Willott E, Balda SM, Fanning AS, Jameson B, Van Itallie CM 1993 The tight junction protein ZO-1 is homologous to the Drosophila discs large tumor suppressor protein of septate junctions. Proc Natl Acad Sci USA 90:7834–7838[Abstract/Free Full Text]
  63. Kloen P, Gebhardt MC, Perez-Atayde A, Rosenberg AE, Springfield DS, Gold LI, Mankin HJ 1997 Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression. Cancer 80:2230–2239[CrossRef][Medline]



This article has been cited by other articles:


Home page
ReproductionHome page
G. A Tarulli, S. J Meachem, S. Schlatt, and P. G Stanton
Regulation of testicular tight junctions by gonadotrophins in the adult Djungarian hamster in vivo
Reproduction, June 1, 2008; 135(6): 867 - 877.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. H. N. Yan, D. D. Mruk, W. M. Lee, and C. Y. Cheng
Blood-testis barrier dynamics are regulated by testosterone and cytokine